AzTrials
AzTrials

Macular DegenerationNCT07216924

Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss

A study testing Personalised Remapping Training, RSVP personalized remappi and Reading text in the wild with remapping in people with Macular Degeneration and Central Visual Impairment, run by University of Minnesota at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Reading performance in patients with Central Vision Loss will be measured with and without missing text being remapped to different parts of the visual field in a variety of different reading tasks. Read more about this study

Who is it for?
Ages 16 years and older
What is being tested?
Personalised Remapping Training, RSVP personalized remappi and Reading text in the wild with remapping
Could I receive a placebo?
No, everyone receives an active treatment
How many people
216 participants
Where
1 siteUnited States
Study dates
Jun 2027to May 2032
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Dense bilateral scotomas of at least 2 deg diameter in each eye covering the fovea
  • Bivariate contour ellipse area (BCEA) of less than 10^2 is obtained in a simple fixation task

Who cannot join

  • Neovascular AMD
  • Any history of visual disorders other than that causing the central vision loss.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Stephen A Engel, Ph.D. contact

6126255571

engel@umn.edu

United States1 site
  • University of Minnesota

    Edina, Minnesota, 55416

    Stephen A Engel, Ph.D., 952-285-2895, engel@umn.edu

    engel@umn.edu

Other trials in United States

About this study

Reading performance in patients with Central Vision Loss will be measured with and without missing text being remapped to different parts of the visual field in a variety of different reading tasks.

Read the detailed description

Following initial characterization of their visual field loss, the participant's performance in various reading tasks will be measured with and without remapping. Tasks will include reading simple sentences, reading popular fiction, reading text with one word presented at a time (rapid serial visual presentation, RSVP), and reading text in simulated real-world environments in virtual reality (e.g. subway station, school, city street). Different remapping strategies, e.g. mainly shifting the text horizontally, or vertically, will be tested.

Participants interested in the study will be brought in for an initial visit where they will first be consented. Participants will then undergo a standard exam at the UMN eye clinic, if they have not had one within the last month. Participants will then have their scotomas mapped using a microperimeter housed in the Ophthalmology department to give size and shape information. Participants will perform visual tasks that are used as the basis of their personalized remapping, letter perimetry. Participants will first view and report three randomly selected horizontally arranged letters placed at different locations in the visual field. This letter perimetry task will take about 40 min and will cover a large part of the visual field. Participants will then read single words whose letters have been displaced from horizontal in various ways that comprise candidate remappings generated on the basis of the letter perimetry results. This personalization test will take about 40 minutes, and will find a good remapping strategy for the individual. Subjects will then be introduced to the reading tasks that comprise the remainder of the study The study then branches into three arms. In one arm, participants will be given repeated practice reading sentences with remappings. In XX additional sessions, participants will perform a single sentence reading tasks for remapped and non-remapped text: One sentence at a time will be displayed on the screen, and the task is simply to read aloud what was presented. Following blocks of this task with and without remapping, participants will be given extended practice reading with remapping. Participants read multiple sentences from a longer text (popular fiction) in multiple 10 minute blocks. Each sentence will be presented individually, and participants will continuously read one sentence after another taken from the fiction text.

In a second arm, participants will read sentences with one word at a time presented in rapid succession. This form of reading is called rapid serial visual presentation or RSVP. In an initial block of sentences, different word rates will be tested to determine the fastest rate where participants are accurate, with and without remapping. Then individual sentences and longer passages will be read as in the other arm, but with this different presentation method. Different remappings and no remapping will again be tested.

In a third arm, participants will read single words presented in naturalistic scenes viewed in a virtual reality environment and presented on a head mounted display. Words will be read with and without remapping. Several different environments will be tested (e.g. subway station, school, city street). The words will be natural text that could be found in these environments, e.g. subway station names, messages on a chalkboard, storefront shop names, etc.

In all sessions in all arms, the eye tracker will be calibrated to participants' individual head and eye position. This will involve fixating at different points on the device screen (HMD or desk-mounted) as the eye is imaged by the eye trackers. Throughout all testing, patients will be asked if they feel any discomfort, and will be able to take a break or quit testing at any point. Reading responses will be verbal and will scored for accuracy by a research assistant.

Including the initial visit, testing for any given patient is anticipated to last no more than 16 sessions over sixteen weeks. Enrolling participants, testing, and data analysis for all participants is anticipated to take five years from the date of enrollment of the first participant.

Being tested
Personalised Remapping Training, RSVP personalized remappi, Reading text in the wild with remapping
Keywords
Reading, Central Field Loss
Medical subject headings
Macular Degeneration, Blindness, Cortical

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Personalised Remapping TrainingBehavioural

    Participants will receive training across multiple days with text being shifted in real time as it is being read from locations covered by scotoma to locations determined by personalization procedure .

  • RSVP personalized remappiBehavioural

    Participants will read one word at a time presented in rapid succession at fixation with text being shifted from scotoma locations to locations determined by personalization procedure.

  • Reading text in the wild with remappingBehavioural

    Participants will read short texts presented in natural scenes in virtual reality with text being shifted from scotoma locations to locations determined by personalization procedure.

Study groups in NCT07216924
Study groupRoleWhat they receive
Perceptual LearningExperimentalParticipants will practice reading with remapping over many sessions on different days.
Receives: Behavioral: Personalised Remapping Training
Rapid Serial Visual PresentationExperimentalParticipants will read words presented one at a time in rapid succession near fixation.
Receives: Behavioral: RSVP personalized remappi
Reading in The WildExperimentalParticipants will view scenes in virtual reality showing natural settings and read a single word at a time within those scenes- e.g. a name on a street sign or shop in a city scene.
Receives: Behavioral: Reading text in the wild with remapping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sentence reading speed

    Time it took to read sentence in words per minute

    Measured: Measured on day 35, end of the Personalised Remapping Training in the 33 participants in the Perceptual Learning arm.

  2. Sentence reading accuracy

    Percentage of correctly read words in sentence

    Measured: Measured on day 35, end of the Personalised Remapping Training in the 33 participants in the Perceptual Learning arm.

  3. Word reading speed: RSVP

    Time taken to read each word

    Measured: Measured on day 21, end of the RSVP Remapping intervention in the 33 participants in the Rapid Serial Visual Presentation arm.

  4. Word recognition accuracy: RSVP

    Percentage of words correctly read

    Measured: Measured on day 21, end of the RSVP Remapping intervention in the 33 participants in the Rapid Serial Visual Presentation arm.

  5. Word reading speed: Reading in The Wild

    Time taken to read each word

    Measured: Measured on day 21, end of the Reading Text in The Wild with Remapping intervention in the 33 participants in the Reading in The Wild arm.

  6. Word recognition accuracy: Reading in the wild

    Percentage of words correctly read

    Measured: Measured on day 21, end of the Reading Text in The Wild with Remapping intervention in the 33 participants in the Reading in The Wild arm.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2025
  2. Study startJun 2027 (estimated)
  3. Primary completionMay 2031 (estimated)
  4. Study completionMay 2032 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
216 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07216924
Sponsor's protocol ID
Remapping in reading tasks
Status last verified
Oct 2026
First submitted
22 Sep 2025
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Psychophysical (behavioral) data on reading will be gathered from 32 participants each in 3 experiments. Scotoma shape and location and location used for fixation will also be gathered for each participant. All data will be deidentified prior to storage in the repository.

Questions about this trial

What is this clinical trial studying?

A study testing Personalised Remapping Training, RSVP personalized remappi and Reading text in the wild with remapping in people with Macular Degeneration and Central Visual Impairment, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Stephen A Engel, Ph.D. (6126255571, engel@umn.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sentence reading speed (time frame: Measured on day 35, end of the Personalised Remapping Training in the 33 participants in the Perceptual Learning arm.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in